Skip to main content

Table 1 Associations between AGGF1 expression and clinicopathological characteristics in 236 CRC patients

From: Elevated expression of AGGF1 predicts poor prognosis and promotes the metastasis of colorectal cancer

VariablenAGGF1 expressionp value
  Negative (46)Weak positive (76)Strong positive (114) 
Age (yr)    0.837
  < 5711222 (19.6%)34 (30.4%)56 (50.0%) 
  > =5712424 (19.4%)42 (33.9%)58 (46.8%) 
Gender    0.359
 Male13923 (16.5%)45 (32.4%)71 (51.1%) 
 Female9723 (23.7%)31 (32.0%)43 (44.3%) 
Tumor location    0.381
 Right495 (10.2%)15 (30.6%)29 (59.2%) 
 Transverse51 (20.0%)2 (40.0%)2 (40.0%) 
 Left122 (16.7%)3 (25.0%)7 (58.3%) 
 Sigmoid497 (14.3%)16 (32.7%)26 (53.1%) 
 Rectum12131 (25.6%)40 (33.1%)50 (41.3%) 
T classification    < 0.001*
 T 122 (100.0%)0 (0.0%)0 (0.0%) 
 T 23621 (58.3%)7 (19.4%)8 (22.2%) 
 T 3447 (15.9%)21 (47.7%)16 (36.4%) 
 T 415416 (10.4%)48 (31.2%)90 (58.4%) 
N classification    < 0.001*
 N 010836 (33.3%)44 (40.7%)28 (25.9%) 
 N 1777 (9.1%)18 (23.4%)52 (67.5%) 
 N 2513 (5.9%)14 (27.5%)34 (66.7%) 
M classification    0.012*
 M 020444 (21.6%)69 (33.8%)91 (44.6%) 
 M 1322 (6.3%)7 (21.9%)23 (71.9%) 
AJCC stage    < 0.001*
 I2419 (79.2%)5 (20.8%)0 (0.0%) 
 II7615 (19.7%)36 (47.4%)25 (32.9%) 
 III10410 (9.6%)28 (26.9%)66 (63.5%) 
 IV322 (6.3%)7 (21.9%)23 (71.9%) 
Recurrence    0.004*
 No19943 (21.6%)69 (34.7%)87 (43.7%) 
 Yes373 (8.1%)7 (18.9%)27 (73.0%) 
Differentiation    0.640
 Well508 (16.0%)17 (34.0%)25 (50.0%) 
 Moderate17334 (19.7%)57 (32.92%)82 (47.4%) 
 Poor134 (30.8%)2 (15.4%)7 (53.8%) 
  1. *Significant difference